The non-pharmaceutical interventions may affect the advantage in transmission of mutated variants during epidemics: a conceptual model for COVID-19
DOI10.1016/J.JTBI.2022.111105zbMATH Open1489.92191OpenAlexW4220741665WikidataQ113293739 ScholiaQ113293739MaRDI QIDQ2137459FDOQ2137459
Maggie H. Wang, Lefei Han, Kai Wang, Marc K. C. Chong, Shi Zhao, Salihu Sabiu Musa, Daihai He, Mu He
Publication date: 16 May 2022
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2022.111105
Recommendations
- Multiscale models of COVID-19 with mutations and variants
- Evaluating the impacts of relaxation and mutation in the SARS-CoV-2 on the COVID-19 epidemic based on a mathematical model: a case study of São Paulo state (Brazil)
- Vaccine hesitancy promotes emergence of new SARS-CoV-2 variants
- Coupling compartmental models with Markov chains and measure evolution equations to capture virus mutability
- A multi-strain model with asymptomatic transmission: application to COVID-19 in the US
COVID-19mathematical modellingreproduction numbernon-pharmaceutical interventiontransmission advantage
Epidemiology (92D30) Qualitative investigation and simulation of ordinary differential equation models (34C60)
Cites Work
Cited In (3)
This page was built for publication: The non-pharmaceutical interventions may affect the advantage in transmission of mutated variants during epidemics: a conceptual model for COVID-19
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2137459)